BONINI, Sergio
 Distribuzione geografica
Continente #
NA - Nord America 4.295
EU - Europa 4.045
AS - Asia 617
SA - Sud America 36
AF - Africa 12
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 5
Totale 9.020
Nazione #
US - Stati Uniti d'America 4.281
IE - Irlanda 1.318
UA - Ucraina 981
GB - Regno Unito 620
DE - Germania 374
SG - Singapore 276
FI - Finlandia 251
SE - Svezia 191
GR - Grecia 150
TR - Turchia 148
CN - Cina 99
IT - Italia 92
IN - India 33
BE - Belgio 22
BR - Brasile 21
KR - Corea 16
ID - Indonesia 11
NL - Olanda 9
FR - Francia 8
EU - Europa 7
MX - Messico 7
PK - Pakistan 7
CA - Canada 6
EC - Ecuador 6
CZ - Repubblica Ceca 5
DZ - Algeria 5
ES - Italia 5
JO - Giordania 5
JP - Giappone 5
BD - Bangladesh 4
CO - Colombia 4
AP - ???statistics.table.value.countryCode.AP??? 3
AR - Argentina 3
GG - Guernsey 3
NZ - Nuova Zelanda 3
RU - Federazione Russa 3
AU - Australia 2
HK - Hong Kong 2
IQ - Iraq 2
IR - Iran 2
LT - Lituania 2
LY - Libia 2
PL - Polonia 2
PT - Portogallo 2
RS - Serbia 2
TH - Thailandia 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BY - Bielorussia 1
CL - Cile 1
DK - Danimarca 1
EG - Egitto 1
GM - Gambi 1
MA - Marocco 1
MY - Malesia 1
NA - Namibia 1
NO - Norvegia 1
PA - Panama 1
PE - Perù 1
RO - Romania 1
SC - Seychelles 1
VN - Vietnam 1
Totale 9.020
Città #
Jacksonville 1.463
Dublin 1.317
Chandler 552
Santa Clara 249
Princeton 245
Medford 233
San Mateo 167
Boardman 160
Singapore 150
Wilmington 115
Ann Arbor 89
Woodbridge 66
Roxbury 56
Cambridge 54
Des Moines 36
Ashburn 30
Beijing 20
New York 18
Redwood City 18
Mountain View 17
Nanjing 16
Brussels 15
Düsseldorf 15
Pune 14
Rome 12
Houston 11
Jinan 11
Norwalk 11
Kunming 8
São Paulo 8
Fairfield 7
Los Angeles 7
Auburn Hills 6
London 6
Tianjin 6
Bremen 5
Città di Castello 5
Haikou 5
Nanchang 5
Orange 5
Quito 5
Seattle 5
Shanghai 5
Dhaka 4
Groningen 4
Hebei 4
L'aquila 4
Longueville 4
Malappuram 4
Pakistan 4
Seoul 4
Třebíč 4
Arzano 3
Brantford 3
Duncan 3
Helsinki 3
Lappeenranta 3
Oristano 3
Patras 3
St Peter Port 3
Taiyuan 3
Venice 3
Belgrade 2
Berlin 2
Bogotá 2
Capannelle 2
Caserta 2
Champaign 2
Changsha 2
Flensburg 2
Gangseo-gu 2
Ghent 2
Hangzhou 2
Hanover 2
Hong Kong 2
Jūnāgadh 2
Lahore 2
Lanzhou 2
Madrid 2
Melbourne 2
Milan 2
Missaglia 2
Munro 2
Naples 2
Patna 2
Pavia 2
Saint Ives 2
Shenyang 2
Stony Brook 2
Taichung 2
Toronto 2
Vanzaghello 2
Adana 1
Amsterdam 1
Andover 1
Appiano Gentile 1
Avellino 1
Bandung 1
Bangkok 1
Berkeley 1
Totale 5.382
Nome #
Global Allergy and Asthma European Network: Grading of Recommendations Assessment, Development and Evaluation Working Group: Allewrgic Rhinitis and its Impact on Asthma (ARIA) Guidelines: 2010 revision 195
Allergic Rhinitis and its Impact on Asthma (ARIA): In collaboration with the World Health Organization 114
A case-control study of the relation between plasma selenium and asthma in European populations: a GAL2EN project 64
POLLENOSIS 2000. GLOBAL APPROACH 64
GA(2)LEN (Global Allergy and Asthma European Network): European network of excellence for asthma and allergic diseases 62
The genetics of atopy 62
Uso del Fattore di crescita nervoso (NGF)per l'espansione in vitro di cellule staminali del cordone ombelicale 62
Uso dei probiotici nella prevenzione e nel trattamento delle congiuntiviti allergiche 59
GA2LEN (GLOBAL ALLERGY AND ASTHMA EUROPEAN NETWORK) ADDRESSES THE ALLERGY AND ASTHMA 'EPIDEMIC' 58
Epidemiology of allergic occupational diseases induced by Tetranychus urticae in greenhouse and open-field farmers living in a temperate climate area 58
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy 56
A multicentric study on sensitivity and specificity of a new in vitro test for measurement of IgE antibodies 56
Methodology for development of the Allergic Rhinitis and its Impact on Asthma guideline 2008 update 55
GA(2)LEN SKIN TEST STUDY I: GA(2)LEN HARMONIZATION OF SKIN PRICK TESTING: NOVEL SENSITIZATION PATTERNS FOR INHALANT ALLERGENS IN EUROPE 54
Lymphocytotoxic HLA antibodies and HB infection in transfused hemodialysis patients waiting for kidney transplantation 54
Nerve growth factor (NGF): an important molecule for trophism and healing of the ocular surface 54
Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen) 53
Recommendations for the standardization of clinical outcomes used in allergen immunotherapy trials for allergic rhinoconjunctivitis: an EAACI Position Paper. 53
Prophylactic management of children at risk for recurrent upper respiratory infections: the Preventia I Study. 53
Reply 53
Integrated care pathways for airway diseases (AIRWAYS-ICPs). 52
Rhinitis and asthma in athletes: an ARIA document in collaboration with GA2LEN 52
Microbial products in allergy prevention and therapy 51
Nerve Growth Factor effect on human primary fibroblastic-keratocytes: possible mechanism during corneal healing 51
Adult SURF Study Group. A survey of clinical features of allergic rhinitis in adults 51
Dampness in buildings as a risk factor for health effects, EUROEXPO: a multidisciplinary review of the literature (1998-2000) on dampness and mite exposure in buildings and health effects. 50
Efficacy of lodoxamide eye drops on mast cells and eosinophils after allergen challenge in allergic conjunctivitis 50
The eosinophil and the eye 50
Nerve growth factor promotes corneal healing: structural, biochemical, and molecular analyses of rat and human corneas 50
Increased plasma levels of nerve growth factor in vernal keratoconjunctivitis 50
Desloratadina: a new approach in the treatment of allergy as a systemic disease - pharmacology and clinical overview 50
Severe Chronic Allergic (and Related) Diseases: A Uniform Approach - A MeDALL - GA(2)LEN - ARIA Position Paper. 49
EXERCISE-INDUCED ASTHMA, RESPIRATORY AND ALLERGIC DISORDERS IN ELITE ATHLETES: EPIDEMIOLOGY, MECHANISMS AND DIAGNOSIS: PART I OF THE REPORT FROM THE JOINT TASK FORCE OF THE EUROPEAN RESPIRATORY SOCIETY (ERS) AND THE EUROPEAN ACADEMY OF ALLERGY AND CLINICAL IMMUNOLOGY (EAACI) IN COOPERATION WITH GA2LEN 49
Primer di Allerghologia e Immunologia Clinica 49
Non specific provocation of target organs in allergic diseases 48
Allergen extracts. Standardization of preparations for bronchial provocation tests. A position paper. (EAACI Sub-committee on Bronchial Provocation Tests) 48
Tear levels of neuropeptides increase after specific allergen challenge in allergic conjunctivitis. 48
Global Approach to the atopic Patient 48
GA(2)LEN SKIN TEST STUDY II: CLINICAL RELEVANCE OF INHALANT ALLERGEN SENSITIZATIONS IN EUROPE 47
Allergenic pollen and pollen allergy in Europe 47
Reply to the letter of Dr. Feinberg in J Allergy Clin Immunol 1990; 85:141-2 47
WHO Intiative. Allergic Rhinitis and its Impact on Asthma (ARIA) 47
Copyright. AQUE. Allergy Questionnaire for Exercisers 47
Pooling birth cohorts in allergy and asthma: European Union-funded initiatives - a MeDALL, CHICOS, ENRIECO, and GA²LEN joint paper 46
Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA(2)LEN and InterAirways document 46
Topical treatment with nerve growth factor for corneal neurotrophic ulcers 46
Nerve Growth Factor and tissue repair remodeling : trkA (NGFR) and p75 (NTR) two receptors one fate. 45
Practical approach to diagnosis and treatment of ocular allergy: a 1-year systematic review 45
The CONSORT statement checklist in allergen-specific immunotherapy: a GA2LEN paper 45
GA2LEN SKIN TEST STUDY III: MINIMUM BATTERY OF TEST INHALENT ALLERGENS NEEDED IN EPIDEMIOLOGICAL STUDIES IN PATIENTS 45
International consensus on allergy immunotherapy 45
Allergen immunotherapy on the way to product-based evaluation - a WAO statement 45
Bridging allergologic and botanical knowledge in seasonal allergy, 44
What we should learn from the London Olympics. 44
Allergy, asthma and markers of infections among Albanian migrants to Southern Italy. 44
Increased serum levels of eosinophil cationic protein and eosinophil-derived neurotoxin (protein X) in vernal keratoconjunctivitis 44
Copyright. AQUA Allergy Questionnaire for Athletes 44
Building bridges for innovation in ageing: Synergies between Action Groups of the EIP on AHA 44
Effects of Salmeterol on Skeletal Muscle Cells: Metabolic and Pro-Apoptotic Features. 43
Which population level environmental factors are associated with asthma, rhinoconjunctivitis and eczema? Review of the ecological analyses of ISAAC Phase One 43
Standard skin prick testing and sensitization to inhalant allergens across Europe – a survey from the GA2LEN network 43
Nerve Growth Factor has a modulatory role on human primary fibroblast coltures derived from vernal keratoconjunctivitis-affected conjunctiva 43
[Phadiatop, a new in vitro method in the diagnosis and prevention of respiratory allergic diseases] 43
Allergic chronic inflammation of the ocular surface in vernal keratoconjunctivitis 43
Desloratadine: a new approach in the treatment of allergy as a systematic disease--pharmacology and clinical overview. Introduction 43
Copyright. QUAQUA. Quality of life Questionnaire for Athletes 43
First-in-human clinical trials - What we can learn from tragic failures 43
The relation between paracetamol use and asthma: a GA2LEN European case-control study 42
Markers of eosinophilic inflammation in allergic diseases 42
Clinical trials in allergic conjunctivits: a systematic review. 42
T-helper 17 lymphocytes in ocular cicatricial pemphigoid 42
Allergic bronchial airway inflammation in Nerve Growth Factor (NGF) – derived rats: evidence suggesting a neuroimmunomodulatory role of NGF 42
IgE serum levels in urinary schistosomiasis 42
Why is the incidence of asthma increasing? 42
Weight loss interventions in asthma: EAACI evidence-based clinical practice guideline (part I). 41
Intestinal permeability in patients with adverse reactions to food 41
Immunological profile of peripheral blood eosinophils in acute graft-vs-host disease 41
Protocolli Allergologici e Immunologici per la Gestione degli Atleti Agonisti e Non-Agonisti 41
Increased plasma levels of substance P in vernal keratoconjunctivitis 41
CLOSE CORRELATION BETWEEN ANXIETY; DEPRESSION; AND ASTHMA CONTROL, 41
Effects of topical pre-treatment with dexamethasone on the immediate and late phases of topically induced ocular anaphylaxis in the rat 41
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 41
An allergist is the new Executive Director of the European Medicine Agency.Editorial. 41
Tear tryptase levels and allergic conjunctivitis 40
Evidence of non reproducibility. Human basophil histamine release is not triggered by very diluted anti-IgE. Letter 40
Allergen dose response and late symptoms in a human model of ocular allergy 40
Allergic conjunctivitis 39
Epidemiology of rhinitis and conjunctivitis in athletes. 39
Exercise-induced hypersensitivity syndromes in recreational and competitive athletes: a PRACTALL consensus report (what the general practitioner should know about sports and allergy) 39
The role of shock organs in influencing the clinical expression of allergy 39
Airway inflammation in the elite athlete and type of sport 39
[New methods in allergology] 39
TLR4 and TLR9 Expression in Different Phenotypes of Rhinitis. 39
Immunophenotypic profile of peripheral blood eosinophils in acute graft-vs.-host disease 38
Eosinophil cationic protein serum levels and allergy in chronic fatigue syndrome 38
Flow cytometric evaluation of activated eosinophils in graft versus host disease and hypereosinophilic conditions 38
[Autoimmunity and lymphoproliferative diseases (proceedings)] 38
IgG subclass antibodies against Parietaria judaica in normal and allergic subjects 38
Manual of Clinical Trials in Allergy and Clinical Immunology 38
Unmet needs in severe chronic upper airway disease (SCUAD) 37
Totale 4.850
Categoria #
all - tutte 43.077
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.077


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020713 0 0 0 0 244 15 261 10 139 17 20 7
2020/20211.814 226 0 259 60 269 4 254 245 0 281 181 35
2021/20221.233 173 1 2 14 492 3 20 38 46 4 94 346
2022/20232.186 251 3 8 169 190 179 1 146 1.151 12 43 33
2023/2024912 72 23 31 131 374 37 4 30 13 9 40 148
2024/2025376 13 20 27 62 254 0 0 0 0 0 0 0
Totale 9.098